Bioassays

Bioassays are an integral part of the overall quality strategy for bio-pharmaceutical products.

Protagen AG provides the following assays:

  • Cell based bioassays, e.g. proliferation, cytotoxicity
  • ELISA
  • Unique bioassay platform for therapeutic antibodies based on Protein Microarrays

For these assays, Protagen AG offers in close collaboration with its clients:

  • GMP and non GMP analysis under highest quality standards
  • Transfer and establishing of existing assays
  • Optimization of bioassays using
    • Design of experiments (DOE)
    • Protein Microarrays for selection of specific detection antibodies
  • Assay validation according to ICH Q2 (R1) and USP
  • Batch release, stability and comparability testing

Protagen uniquely combines bioassays with structural and functional protein analysis: 

  • well accepted analytical techniques (HPLC, PAGE etc) and
  • sophisticated mass spectrometry
  • modern quality management techniques like risk assessment

This portfolio is completed by profound expertise in bioinformatic data analysis and statistics.

Please This e-mail address is being protected from spambots. You need JavaScript enabled to view it  Protagen for further information.


Example: G-CSF potency assay: Determination of biological activity of G-CSF (Filgrastim) according to PharmEu monograph <2206>.